RELAPSING FORMS OF MULTIPLE SCLEROSIS

Clinical trials for RELAPSING FORMS OF MULTIPLE SCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear

Sign up with your email to follow new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 3

New hope for kids with MS: major trial tests promising treatments

Disease control Not yet recruiting

This study is testing two oral medications, diroximel fumarate (DRF) and dimethyl fumarate (DMF), in children and teenagers with relapsing forms of multiple sclerosis (MS). The main goals are to see how safe these drugs are for young people and to compare how well they control MS…

Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS

Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RELAPSING FORMS OF MULTIPLE SCLEROSIS

Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear

New hope for kids with MS: major trial tests promising treatments